{"id":"W2910682218","doi":"10.2967/jnumed.118.220095","title":"Preclinical Evaluation of<sup>111</sup>In-Labeled PEGylated Maytansine Nimotuzumab Drug Conjugates in EGFR-Positive Cancer Models","year":2019,"lang":"en","type":"article","venue":"Journal of Nuclear Medicine","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal University Hospital; University of Saskatchewan","funders":"","keywords":"Nimotuzumab; Biodistribution; In vivo; Chemistry; PEG ratio; Ex vivo; Pharmacokinetics; Antibody-drug conjugate; DOTA; Monoclonal antibody; Epidermal growth factor receptor; In vitro; Pharmacology; Antibody; Medicine; Receptor; Biochemistry; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00581033,0.0002430715,0.001285986,0.0007285184,0.00002453318,0.00001025093,0.0002806788,0.0002046083,0.003313159],"category_scores_gemma":[0.001244784,0.0001827707,0.0001351398,0.0007531997,0.0002541344,0.000272046,0.00006555489,0.001306621,0.000036432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001183351,"about_ca_system_score_gemma":0.001205816,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007185219,"about_ca_topic_score_gemma":0.000109027,"domain_scores_codex":[0.9946043,0.0005554557,0.001698336,0.0003314495,0.0023709,0.0004395763],"domain_scores_gemma":[0.9964226,0.0005192617,0.0005911495,0.0003715041,0.001800911,0.0002946047],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.06348138,0.00687254,0.2743448,0.003866869,0.00312743,0.002650208,0.08507474,0.1742862,0.163692,0.001242485,0.07956297,0.1417984],"study_design_scores_gemma":[0.06686182,0.008853049,0.1257046,0.01982159,0.001084305,0.0005306492,0.006562744,0.7638811,0.001727048,0.001675027,0.002791012,0.0005070269],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9717981,0.004092829,0.000004392979,0.01940332,0.0003091657,0.001006049,0.000008565026,0.00001178373,0.003365831],"genre_scores_gemma":[0.9963884,0.001753791,0.0002399556,0.0008215936,0.0004631469,0.00000693111,0.000007810097,0.00006466689,0.0002537417],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5895949,"threshold_uncertainty_score":0.9975979,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09107480338629023,"score_gpt":0.4276933108519808,"score_spread":0.3366185074656906,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}